Newsroom

Sorted by: Latest

-

Trimontium Launches with $1.5 billion in AUM, Redefining Flexible Capital Solutions

LONDON--(BUSINESS WIRE)--Trimontium (the “Firm”), an institutionally backed alternative asset manager specialising in flexible capital solutions, today announced its launch with $1.5 billion in assets under management. The Firm’s investment approach is rooted in credit and special-situations expertise, with the flexibility to originate and execute tailored financing solutions across the full capital structure for a wide range of corporate needs. Founded by former Blackstone executive Vlado Spas...
-

Mr. Clean Reinvents the Everything Shower with First-Ever Beauty Campaign for the Mr. Clean Shower & Tub Scrubber

CINCINNATI--(BUSINESS WIRE)--Mr. Clean is crashing the Everything Shower trend, dropping his first-ever beauty-inspired moment and crowning the Shower & Tub Scrubber as the ultimate glow-up device for your bathroom. Mr. Clean may be back from retirement, but he didn’t spend his time off lounging. During his break, he dove headfirst into the rising self-care trend of the Everything Shower—and quickly realized that while people were busy pampering their skin, hair, and every serum-soaked inch...
-

オアシス、京セラにおける取締役会の説明責任および監督機能の強化を支持するISSおよびグラスルイスの推奨を歓迎

香港--(BUSINESS WIRE)--(ビジネスワイヤ) -- オアシス・マネジメント・カンパニー・リミテッド(以下「オアシス」または「当社」)は、京セラ株式会社(6971 JP)(以下、「京セラ」または「同社」)の株式を保有するファンドの運用会社です。オアシスは、2026年6月25日に開催予定の京セラ定時株主総会に関し、世界を代表する独立系議決権行使助言会社であるInstitutional Shareholder Services(以下、「ISS」)およびGlass Lewis & Co.(以下、「Glass Lewis」)が公表した推奨内容を歓迎します。 ISSおよびGlass Lewisは、京セラの株主の皆様に対して、以下のとおり議決権を行使するよう推奨しています。 会社提案である山口悟郎会長の取締役選任議案(第3号議案・候補者番号1)に反対票を投じること オアシスによる株主提案である山口会長の取締役解任議案(第10号議案)に賛成票を投じること オアシスによる株主提案である岡村宏太郎氏の取締役選任議案(第11号議案および第12号議案)に賛成票を投じること また、IS...
-

Oasis Welcomes ISS and Glass Lewis Recommendations Supporting Board Accountability and Stronger Oversight at Kyocera

HONG KONG--(BUSINESS WIRE)--Oasis Management Company Ltd. (“Oasis”), the investment manager to private funds that owns shares in KYOCERA CORPORATION (“Kyocera” or the “Company”), today welcomed the recommendations of the two leading independent proxy advisory firms, Institutional Shareholder Services (“ISS”) and Glass Lewis & Co. (“Glass Lewis”), in connection with the Company’s AGM scheduled for June 25, 2026. ISS and Glass Lewis recommend that Kyocera shareholders: Vote AGAINST the Compan...
-

Thanx and Kea Bring Guest Recognition to the Phone Channel

SAN FRANCISCO & PALO ALTO, Calif.--(BUSINESS WIRE)--Thanx and Kea integrate loyalty and Voice AI, enabling guest recognition, enrollment, and rewards for restaurant phone orders....
-

Samenvatting: Pelago Bioscience neemt RG Discovery over om een geïntegreerde partner voor het ontdekken van geneesmiddelen te vormen, die biologie en chemie omspant

STOCKHOLM & LUND, Zweden--(BUSINESS WIRE)--Pelago Bioscience, een gespecialiseerde CRO (contract research organization) die zich richt op het ontdekken van geneesmiddelen en bekend staat om zijn sectorleidende celgebaseerde methode om binding aan het doelwit te meten (cell-based target engagement assays), kondigt tevreden de overname aan van RG Discovery, waarmee het bedrijf grondige expertise in farmacochemie, synthese op maat en geïntegreerde ontdekking van geneesmiddelen toevoegt. Door Pelag...
-

CALX INVESTOR REMINDER: Calix, Inc. Investors Have Until July 27, 2026 To Seek Lead Plaintiff Role

NEW YORK--(BUSINESS WIRE)--If you have suffered a loss on your Calix, Inc. (“Calix” or the “Company”) (NYSE:CALX) investment, contact Lauren Molinaro of Kirby McInerney LLP by email at investigations@kmllp.com, or fill out the contact form below to discuss your rights or interests in the securities fraud class action lawsuit at no cost. Investors have until July 27, 2026 to ask the Court to appoint them as lead plaintiff. Courts do not consider applications filed after this deadline. The lead p...
-

INVESTOR ALERT: Securities Class Action Filed Against Nano-X Imaging Ltd. – Investors Encouraged to Contact Kirby McInerney LLP

NEW YORK--(BUSINESS WIRE)--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Nano-X Imaging Ltd. (“Nano-X” or the “Company”) (NASDAQ:NNOX) securities during the period of March 31, 2025 through April 17, 2026, inclusive (“the Class Period”). If you suffered a loss on your Nano-X investments, you have until August 11, 2026 to request lead plaintiff appointment. Courts do not consider lead plaintiff applications submitted...
-

Murchinson Criticizes the Nano Dimension Board of Directors’ Decision to Pursue a Seemingly Deeply Flawed Transaction with Infinite Epigenetics

TORONTO--(BUSINESS WIRE)--Murchinson Ltd. (collectively with its affiliates and funds it advises and/or sub-advises, "Murchinson" or "we"), a significant shareholder with approximately 7.4% of the outstanding shares of Nano Dimension Ltd. (NASDAQ: NNDM) ("Nano" or the "Company"), today commented on Nano’s announcement that it has signed a non-binding term sheet with Infinite Epigenetics (“Infinite” or “Infinite Epigenetics”) to form a publicly traded, AI-powered health and diagnostics company.1...
-

OG Anunoby Is First Player to Win NBA Championship in Skechers

LOS ANGELES--(BUSINESS WIRE)--New York’s historic NBA playoff run and Finals victory had fans around the world celebrating the outstanding performance of Knicks star forward OG Anunoby. Backed by the brand’s signature Comfort That Performs®, OG also made history as the first player to ever wear Skechers Basketball footwear on the NBA Finals court. “Skechers has been an exceptional partner on this journey,” said OG Anunoby, now a two-time NBA champion. “I feel like I’m part of the family after on...